New York, April 23, 2004 – Weil, Gotshal & Manges LLP, one of the world’s leading law firms, advised Pfizer Inc [NYSE: PFE] in its definitive agreement with Advanced Medical Optics, Inc. (AMO) [NYSE: AVO] for AMO to acquire Pfizer’s surgical ophthalmology business for $450 million in cash.
AMO is a global leader in the development, manufacturing and marketing of ophthalmic surgical and contact lens care products. Pfizer Inc is a research-based global pharmaceuticals company that discovers, develops, manufactures, and markets innovative medicines for humans and animals.
Weil, Gotshal & Manges LLP is an international law firm of more than 1,100 attorneys, including approximately 300 partners. Weil Gotshal is headquartered in New York, with offices in Austin, Boston, Brussels, Budapest, Dallas, Frankfurt, Houston, London, Miami, Munich, Paris, Prague, Silicon Valley, Singapore, Warsaw and Washington, D.C.
Weil, Gotshal & Manges LLP’s Team
Partners: Raymond O. Gietz (Corporate – New York); Stanley M. Spracker (Environmental – Washington, DC)
Associates: Stefan J. Wright, Louis J. Gambino and Greg H. Stoller (Corporate – New York)
